Search research articles
Contact Us
Filters
Showing results (1-10 of 38) with videos related to
Page
of 4
Sort By:
Cancer Control : Journal of the Moffitt Cancer Center
|
July 16, 2002
Legal and Clinical Issues in Prescribing Controlled Substances
J David Haddox
Journal of Opioid Management
|
January 9, 2018
Opioids with abuse-deterrent properties: A regulatory and technological overview
J David Haddox
Journal of Forensic Sciences
|
June 3, 2004
Commentary on: Burrows DL, Hagardorn AN, Harlan GC, Wallen EDB, Ferslew KE. A fatal drug interaction between oxycodone and clonazepam. J Forensic Sci 2003;48(3):683-86
J David Haddox, Barbara Carrig
Current Medical Research and Opinion
|
May 24, 2007
Comment and reply on: Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain
Nancy Crudele, J David Haddox
Journal of Addiction Medicine
|
July 20, 2011
Corrections to Dosing Recommendations for Oxycodone Extended-release Tablets
Lally Samuel, J David Haddox
Journal of Pain & Palliative Care Pharmacotherapy
|
October 29, 2014
Clarification on transdermal buprenorphine
Erica H Dankiewicz, J David Haddox
Pain
|
November 15, 2016
A tale of 2 ADFs-with 2 different abuse-deterrent formulations
J David Haddox, Richard O Mannion
Journal of Pain & Palliative Care Pharmacotherapy
|
December 3, 2003
Lawful prescribing and the prevention of diversion
Landon S Gibbs, J David Haddox
Convulsive Therapy
|
January 1, 1990
Electroconvulsive Therapy and Fluoxetine
Harold H. Harsch, J. David Haddox
The Journal of School Health
|
October 21, 2009
Development and reliability of items measuring the nonmedical use of prescription drugs for the Youth Risk Behavior Survey: results from an initial pilot test
Melissa M Howard, Robert M Weiler, J David Haddox
Page
of 4
Search research articles
Search
Showing results (1-10 of 38) with videos related to
Sort By:
Page
of 4
Cancer Control : Journal of the Moffitt Cancer Center
|
July 16, 2002
Legal and Clinical Issues in Prescribing Controlled Substances
J David Haddox
Journal of Opioid Management
|
January 9, 2018
Opioids with abuse-deterrent properties: A regulatory and technological overview
J David Haddox
Journal of Forensic Sciences
|
June 3, 2004
Commentary on: Burrows DL, Hagardorn AN, Harlan GC, Wallen EDB, Ferslew KE. A fatal drug interaction between oxycodone and clonazepam. J Forensic Sci 2003;48(3):683-86
J David Haddox, Barbara Carrig
Current Medical Research and Opinion
|
May 24, 2007
Comment and reply on: Randomized trial comparing polymer-coated extended-release morphine sulfate to controlled-release oxycodone HCl in moderate to severe nonmalignant pain
Nancy Crudele, J David Haddox
Journal of Addiction Medicine
|
July 20, 2011
Corrections to Dosing Recommendations for Oxycodone Extended-release Tablets
Lally Samuel, J David Haddox
Journal of Pain & Palliative Care Pharmacotherapy
|
October 29, 2014
Clarification on transdermal buprenorphine
Erica H Dankiewicz, J David Haddox
Pain
|
November 15, 2016
A tale of 2 ADFs-with 2 different abuse-deterrent formulations
J David Haddox, Richard O Mannion
Journal of Pain & Palliative Care Pharmacotherapy
|
December 3, 2003
Lawful prescribing and the prevention of diversion
Landon S Gibbs, J David Haddox
Convulsive Therapy
|
January 1, 1990
Electroconvulsive Therapy and Fluoxetine
Harold H. Harsch, J. David Haddox
The Journal of School Health
|
October 21, 2009
Development and reliability of items measuring the nonmedical use of prescription drugs for the Youth Risk Behavior Survey: results from an initial pilot test
Melissa M Howard, Robert M Weiler, J David Haddox
Page
of 4